MRB-CFI-1

a nanometric compound of metallic salts and phosphate and associated with a glycosidic protein 420-530 nm in size

Also Known As:

OncoTherad; biological response modifier - inorganic phosphate complex 1; biological response modifier inorganic phosphate complex 1; biological response modifier-inorganic phosphate complex 1

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Fávaro, Wagner José: 2 articles (04/2022 - 01/2021)
2.	Durán, Nelson: 1 article (04/2022)
3.	Genaro, Sandra Cristina: 1 article (04/2022)
4.	Reis, Sabrina Karen: 1 article (04/2022)
5.	Socca, Eduardo Augusto Rabelo: 1 article (04/2022)
6.	de Souza, Bianca Ribeiro: 1 article (04/2022)
7.	Name, José João: 1 article (01/2021)
8.	Souza, Ana Carolina Remondi: 1 article (01/2021)
9.	Vasconcelos, Andrea Rodrigues: 1 article (01/2021)

Related Diseases

1.	Non-Muscle Invasive Bladder Neoplasms 01/01/2021 - "On the other hand, OncoTherad, a safe and effective immunotherapeutic agent in the treatment of non‑muscle invasive bladder cancer (NMIBC), increases IFN signaling and has been shown to be a promising therapeutic approach for COVID‑19 in a case report that described the rapid recovery of a 78‑year‑old patient with NMIBC with comorbidities. "
2.	Carcinogenesis 04/01/2022 - "Effects of combined OncoTherad immunotherapy and probiotic supplementation on modulating the chronic inflammatory process in colorectal carcinogenesis." 04/01/2022 - "This study evaluated the effects of combined OncoTherad immunotherapy and probiotic supplementation on colorectal carcinogenesis chemically induced with 1,2-dimethylhydrazine (DMH) in mice. "
3.	Weight Loss (Weight Reduction) 04/01/2022 - "Probiotic supplementation associated with the OncoTherad were able to modulate weight loss, stimulate the canonical signaling pathway TLR2/TLR4 (MyD88-dependent), reduce the non-canonical signaling pathway (TRIF-dependent), attenuate the proliferative pathway mediated by Ki-67 and KRAS oncogene, and stimulate the production of IL-10 and TGF-β cytokines. "
4.	Colorectal Neoplasms (Colorectal Cancer) 04/01/2022 - "Thus, the association of OncoTherad and probiotic supplementation has shown important immudomulatory effects and could be considered a potential new therapeutic approach for colorectal cancer after further investigations."

Related Drugs and Biologics

1.	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)
2.	Dimenhydrinate (DMH)
3.	Interleukin-10 (Interleukin 10)
4.	Cytokines

Related Therapies and Procedures

1.	Immunotherapy